Indices trade with modest losses; pharma shares decline

Image
Capital Market
Last Updated : Jun 29 2022 | 7:50 PM IST

The domestic equity benchmarks further pared losses and with traded with modest cuts in early afternoon trade. After hitting the day's low at 15,687.80 in early trade, the Nifty managed to recoup losses and hovered near the 15,800 level. Pharma shares witnessed selling pressure for second consecutive session.

At 12:24 IST, the barometer index, the S&P BSE Sensex, was down 168.52 points or 0.32% to 53,008.93. The Nifty 50 index fell 58.35 points or 0.37% to 15,791.85.

In the broader market, the S&P BSE Mid-Cap index fell 0.99% while the S&P BSE Small-Cap index lost 0.06%.

The market breadth was almost even. On the BSE, 1,542 shares rose and 1,583 shares fell. A total of 163 shares were unchanged.

Buzzing Index:

The Nifty Pharma index slipped 0.76% to 12,121.30. The index has lost 0.82% in two sessions.

Cipla (down 1.78%), Lupin (down 1.57%), Ipca Laboratories (down 1.46%), Divis Laboratories (down 1.43%) and Biocon (down 1.36%) were the top losers.

Among the other losers were Alembic Pharmaceuticals (down 1.13%), Alkem Laboratories (down 0.96%), Aurobindo Pharma (down 0.88%), Glenmark Pharmaceuticals (down 0.85%) and Strides Pharma Science (down 0.83%).

On the other hand, Abbott India (up 1.21%) ,Gland Pharma (up 0.92%) and Pfizer (up 0.33%) moved up.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, rose 2.29% to 21.94. The Nifty 30 June 2022 futures were trading at 15,771.85, at a discount of 20 points as compared with the spot at 15,791.85.

The Nifty option chain for the 30 June 2022 expiry showed maximum Call OI of 114.5 lakh contracts at the 16,000 strike price. Maximum Put OI of 126.4 lakh contracts was seen at 15,700 strike price.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 29 2022 | 12:25 PM IST

Next Story